Janet Dillione sold $262k of CRMD
director at CorMedix Inc.. 26,343 shares at an average of $9.93, traded Nov 24, 2025, filed Nov 26, 2025.
Score components
- +15RoleDirector
- +13Trade size$262k at market
- +10Share of holdings soldSold 35% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-25-115725, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 24, 2025 | MOption exercise Common Stock | +8,000 | $2.85 | $23k | 56,473 | Nov 26, 2025 |
| Nov 24, 2025 | MOption exercise Common Stock | +7,790 | $4.03 | $31k | 64,263 | Nov 26, 2025 |
| Nov 24, 2025 | MOption exercise Common Stock | +4,876 | $4.43 | $22k | 69,139 | Nov 26, 2025 |
| Nov 24, 2025 | MOption exercise Common Stock | +5,677 | $3.55 | $20k | 74,816 | Nov 26, 2025 |
| Nov 24, 2025 | SOpen-market sale Common Stock | -26,343 | $9.93 | $262k | 48,473 | Nov 26, 2025 |
| Nov 24, 2025 | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -8,000 | $0.00 | $0 | 0 | Nov 26, 2025 |
| Nov 24, 2025 | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -7,790 | $0.00 | $0 | 12,210 | Nov 26, 2025 |
| Nov 24, 2025 | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -4,876 | $0.00 | $0 | 15,124 | Nov 26, 2025 |
| Nov 24, 2025 | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -5,677 | $0.00 | $0 | 24,323 | Nov 26, 2025 |
Related signals
Other insiders at CorMedix Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | CorMedix Inc. | Janet Dillione director | $69k 10,000 shares | -21% | |
| 11Weak | CorMedix Inc. | Alan W Dunton director | $260k 20,000 shares | -33% | |
| 20Weak | CorMedix Inc. | Joseph Todisco Chief Executive Officer | $360k 30,000 shares | -6% | |
| 21Weak | CorMedix Inc. | Janet Dillione director | $408k 34,000 shares | -41% | |
| 58Moderate | CorMedix Inc. | Steven W Lefkowitz director | $475k 40,000 shares | -33% | |
| 15Weak | CorMedix Inc. | Janet Dillione director | $467k 46,657 shares | -49% | |
| 40Moderate | CRMDsell CorMedix Inc. | Janet Dillione director | $343k 30,000 shares | -38% | |
| 40Moderate | CRMDbuy CorMedix Inc. | Myron Kaplan director | $276k 25,000 shares | +14% | |
| 31Weak | CorMedix Inc. | Alan W Dunton director | $131k 10,000 shares | -20% | |
| 45Moderate | CorMedix Inc. | Joseph Todisco Chief Executive Officer | $650k 50,000 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.